CUSIP 75915K309COMRGLSQ1 2025
18 filings · latest Aug 14, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Federated Hermes, Inc. | 15.82M | $39.20M |
| 2 | Nea Management Company, LLC | 6.47M | $11.32M |
| 3 | Octagon Capital Advisors LP | 4.64M | $8.11M |
| 4 | Blackrock, Inc. | 4.17M | $7.30M |
| 5 | Vanguard Group Inc | 3.95M | $6.92M |
| 6 | Deep Track Capital, LP | 3.26M | $5.71M |
| 7 | Vivo Capital, LLC | 2.70M | $4.72M |
| 8 | Baker Bros. Advisors LP | 2.69M | $4.71M |
| 9 |
| 4 | Apr 8, 2025 | Point72 Asset Management, L.P. | 13G | 5.9% | 3.92M | SEC |
| 5 | Nov 14, 2024 | Dafna Capital Management LLC | 13G/A | 1.4% | 895.2K | SEC |
| 6 | Nov 14, 2024 | Ra Capital Management, L.P. | 13G/A | 1.2% | 766.8K | SEC |
| 7 | Nov 14, 2024 | Biotechnology Value Fund L P | 13G/A | 1.0% | 448.9K | SEC |
| 8 | Nov 12, 2024 | Vanguard Group Inc | 13G/A | 6.2% | 4.09M | SEC |
| 9 | Nov 8, 2024 | Blackrock, Inc. | 13G | 6.2% | 4.08M | SEC |
| 10 | Nov 4, 2024 | Vanguard Group Inc | 13G/A | 6.2% | 4.09M | SEC |
See the full Schedule 13D/13G history for Regulus Therapeutics Inc.
Unlock full history| 1.97M |
| $3.44M |
| 10 | Geode Capital Management, LLC | 1.30M | $2.28M |